6.13
+0.46
+(8.11%)
At close: January 10 at 4:00:02 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-38,219.00
-32,694.00
-22,179.00
-23,939.05
-16,704.39
Investing Cash Flow
-39.00
-32.00
-654.00
-525.36
-199.92
Financing Cash Flow
49,095.00
38,613.00
21,202.00
19,393.57
25,061.32
End Cash Position
28,032.00
14,301.00
8,414.00
10,044.51
14,967.09
Capital Expenditure
-42.00
-66.00
-654.00
-525.36
-199.92
Issuance of Capital Stock
12,412.00
6,999.00
21,120.00
5,046.68
24,815.73
Issuance of Debt
19,727.00
10,000.00
--
14,470.00
--
Repayment of Debt
--
--
--
-437.99
--
Repurchase of Capital Stock
--
-150.00
--
--
--
Free Cash Flow
-38,261.00
-32,760.00
-22,833.00
-24,464.40
-16,904.31
12/31/2020 - 2/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHVS Pharvaris N.V.
17.80
-3.99%
CRGX CARGO Therapeutics, Inc.
13.50
-4.93%
CYCCP Cyclacel Pharmaceuticals, Inc.
7.60
-3.55%
ENGN enGene Holdings Inc.
7.61
-6.05%
ENTX Entera Bio Ltd.
2.4500
0.00%
GNFT Genfit S.A.
3.6000
0.00%
IPHA Innate Pharma S.A.
1.7700
-1.67%
ARVN Arvinas, Inc.
18.62
-6.05%
DMAC DiaMedica Therapeutics Inc.
5.27
-3.48%
ACOG Alpha Cognition Inc. Common Stock
6.10
+6.56%